Method and apparatus for effecting hyperthermic treatment

• US 4,181,132 A
• Filed: 05/31/1977
• Issued: 01/01/1980
• Est. Priority Date: 05/31/1977
• Status: Expired due to Term

• Current Assignee: Research Against Cancer Incorporated
• Original Assignee: Leon C. Parks
• Inventors: Parks, Leon C.
• Primary Examiner(s): Michell, Robert W.
• Assistant Examiner(s): Thaler, Michael H.
• Application Number:
  US05/802,033
• Time in Patent Office: 945 Days
• Field of Search: 128/399, 128/400, 128/401, 128/402, 128/214 R, 128/214 A, 128/347, 128/348, 128/303.1, 3/1
• US Class Current: 607/106
• CPC Class Codes: A61M 1/3655 Arterio-venous shunts or fistulae
• CPC Class Codes: A61M 1/369 Temperature treatment
• CPC Class Codes: A61M 2205/3606 cooled
• CPC Class Codes: A61M 2205/366 by liquid heat exchangers

Abstract

A process of hyperthermic treatment of a patient which comprises the steps of establishing a sterile extracorporeal flow path for blood having an inlet, an outlet and a temperature control zone therebetween, establishing communication of the flow path inlet with the patient'"'"'s bloodstream so that blood can be supplied to the extracorporeal flow path without adversely affecting the blood circulation in the area from which the blood is withdrawn, establishing communication of the flow path outlet with the patient'"'"'s bloodstream so that blood is returned to the bloodstream in such a way as to be distributed systemically, pumping blood withdrawn from the patient'"'"'s bloodstream through the temperature control zone at a controlled rate of at least approximately 1 liter per minute and returning the same to the patient'"'"'s bloodstream to be distributed systemically, controlling the temperature of the blood flowing through the temperature control zone for an initial period during which the temperature level of the blood within the zone is raised without subjecting the same to localized temperatures in excess of approximately 45° C. so that the systemic distribution of the returned blood gradually increases the core temperature of the patient'"'"'s body to a generally stable temperature condition at a level of approximately 41.5° C. but not higher than approximately 42.5° C., and maintaining control of the temperature of the blood flowing through the temperature control zone at the generally stable temperature for a second time period sufficient to effect the desired treatment and apparatus for carrying out the method.

Claims

1. A process of retarding the growth of cancer cells in a human patient which comprises the steps of:

establishing a sterile extracorporeal flow path for blood having an inlet, an outlet and a temperature control zone therebetween,

establishing communication of the inlet of said extracorporeal flow path with the patient'"'"'s bloodstream so that blood can be withdrawn and supplied to said extracorporeal flow path without adversely affecting the blood circulation in the areas from which the blood is withdrawn,

establishing communication of the outlet of said extracorporeal flow path with the patient'"'"'s bloodstream so that blood flowing from the extracorporeal flow path is returned to the bloodstream in such a way as to be distributed systemically,

pumping blood withdrawn from the patient'"'"'s bloodstream along said extracorporeal flow path through said temperature control zone at a controlled rate of at least approximately 1 liter per minute and returning the same to the patient'"'"'s bloodstream to be distributed systemically, as aforesaid,

controlling the temperature of the blood flowing along said extracorporeal flow path through said temperature control zone for an initial period during which the temperature level of the blood within the zone is raised without causing the same to reach localized temperatures in excess of approximately 45°

C. so that the systemic distribution of the returned blood generally increases the patient'"'"'s core body temperature to a generally stable temperature condition at a level of approximately 41.5°

C. but not higher than approximately 42.5°

C., and

maintaining control of the temperature of the blood flowing along said extracorporeal flow path through said temperature control zone at said generally stable temperature for a second time period sufficient to effect the desired treatment.

2. A process as defined in claim 1 wherein immediately following said second time period, the flow of blood along said extracorporeal flow path through said temperature control zone is continued for a third time period during which the temperature level of the blood in said zone is lowered until the systemic distribution of the returned blood gradually decreases the patient'"'"'s core body temperature to a generally normal temperature condition.

3. A process as defined in claim 1 wherein said second time period is at least six hours.

4. A process as defined in claim 1 wherein the communication of the inlet of said extracorporeal flow path with the patient'"'"'s bloodstream is effected by communicating the extracorporeal flow path with the femoral artery through a side wall thereof and the communication of the outlet of said extracorporeal flow path with the patient'"'"'s bloodstream is effected by communicating the extracorporeal flow path with the femoral vein through a side wall thereof.

5. A process as defined in claim 1 wherein the temperature of the blood flowing along said extracorporeal flow path through said temperature control zone is controlled by heat exchange with a liquid flowing through said temperature control zone.

6. A process as defined in claim 1 wherein said hyperthermic treatment is carried out with the skin of the patient maintained in a condition similar to that normally maintained in an intensive care hospital room.

7. A process as defined in claim 6 wherein said hyperthermic treatment is carried out with the patient breathing room air.

8. Apparatus for hyperthermic treatment of a human patient for the purpose of retarding the growth of cancer cells in the patient which comprises:

means defining a sterile extracorporeal flow path for blood having an inlet, an outlet and a temperature control zone therebetween,

means for establishing communication of the inlet of said extracorporeal flow path with the patient'"'"'s bloodstream so that blood can be withdrawn and supplied to said extracorporeal flow path without adversely affecting the blood circulation in the areas from which the blood is withdrawn,

means for establishing communication of the outlet of said extracorporeal flow path with the patient'"'"'s bloodstream so that blood flowing from the extracorporeal flow path is returned to the bloodstream in such a way as to be distributed systemically,

means for pumping blood withdrawn from the patient'"'"'s bloodstream along said extracorporeal flow path through said temperature control zone at a controlled rate of at least approximately 1 liter per minute and returning the same to the patient'"'"'s bloodstream to be distributed systemically, as aforesaid, and

means for controlling the temperature of the blood flowing along said extracorporeal flow path through said temperature control zone for an initial period during which the temperature level of the blood within the zone is raised without causing the same to reach localized temperatures in excess of approximately 45°

C. so that the systemic distribution of the returned blood gradually increases the patient'"'"'s core body temperature to a generally stable temperature condition at a level of approximately 41.5°

C. but not higher than approximately 42.5°

C., and for maintaining control of the temperature of the blood flowing along said extracorporeal flow path through said temperature control zone at said generally stable temperature condition for a second time period sufficient to effect the desired treatment.

9. Apparatus as defined in claim 8 wherein said blood temperature controlling means includes heat exchanger means in said temperature control zone for flowing a liquid in heat exchange relation with the blood flowing through said zone.

10. Apparatus as defined in claim 9 wherein said blood temperature controlling means further includes means for maintaining a first body of liquid at a temperature of approximately 45°

C., and means for circulating liquid between said first body and said heat exchanger means.

11. Apparatus as defined in claim 10 wherein said blood temperature controlling means further includes means for maintaining a second body of liquid at a reduced temperature, and means for circulating liquid between said second body and said heat exchanger means.

12. Apparatus as defined in claim 11 wherein said circulating means for said first and second bodies of liquid include means for varying the proportion of flow from said bodies between limits in which the proportionate flow from each body is zero.

13. Apparatus as defined in claim 12 wherein said blood temperature controlling means further includes means for sensing the temperature of (1) the patient'"'"'s core body (2) the blood leaving said heat exchanger means, and (3) the liquid entering said heat exchanger means.

14. Apparatus as defined in claim 13 wherein said inlet to bloodstream communication establishing means and said outlet to bloodstream communication establishing means comprise a totally subcutaneous implant device, a blood withdrawing percutaneous cannula and trocar assembly removably cooperable with said implant device and a blood returning percutaneous cannula and trocar assembly removably cooperable with said implant device.

15. Apparatus as defined in claim 14 wherein said implant device comprises;

a body of elastomeric material adapted to be implanted totally subcutaneously in a femoral extremity,

means in said body defining an arterial passage, a spaced venous passage, and a bypass conduit extending from one end of said arterial passage to one end of said venous passage,

an arterial tube of vascular prosthesis material having one end connected in communicating relation with the other end of said arterial passage and an opposite end adapted to be connected with a main femoral artery side wall in communicating relation with the interior of the femoral artery,

a venous tube of vascular prosthesis material having one end connected in communicating relation with the other end of said venous passage and an opposite end adapted to be connected with a main femoral vein side wall in communicating relation with the interior of the femoral vein,

blood withdrawing percutaneous cannula receiving means in said elastomeric body extending from a position exterior of said elastomeric body inwardly thereof to a position in communicating relation with said arterial passage movable between (1) a closed condition excluding fluid containing space within said body between said two positions so that blood flowing from said arterial tube through said arterial passage will pass therefrom through said bypass conduit into said venous passage and out of said venous tube and (2) an open condition excluding fluid receiving space within said body from the exterior periphery of the portion of a blood withdrawing cannula extending between said two positions which also extends percutaneously and in communicating relation with said arterial passage so that blood flowing from said arterial tube through said arterial passage will flow through said blood withdrawing cannula and said bypass conduit, and

blood returning percutaneous cannula receiving means in said elastomeric body extending from a position exterior of said body inwardly thereof to a position in communicating relation with said venous passage movable between (1) a closed condition excluding fluid containing space within said body between said two positions so that blood flowing from said bypass conduit will pass therefrom into said venous passage and out of said venous tube, and (2) an open condition excluding fluid receiving space within said body from the exterior periphery of the portion of a blood returning cannula extending between said two positions which also extends percutaneously and in communicating relation with the venous passage so that said venous passage will receive blood flowing both from said blood returning cannula and said bypass conduit.

16. Apparatus as defined in claim 15 wherein each of said cannular-trocar assemblies comprises an elongated percutaneous cannula having a subcutaneous end portion and an extracorporeal end portion, said subcutaneous end portion having an exterior peripheral cross-sectional configuration elongated in one direction with sharp points defining opposite ends thereof in the direction of elongation, said cannula having an interior passage extending from the extracorporeal end portion thereof to the extremity of said subcutaneous end portion and an elongated trocar including a pointed end, said trocar having an exterior periphery extending from said pointed end of a shape to enable said trocar (1) to be inserted pointed end first through said interior passage of said cannula in a direction and to an extent sufficient to position the pointed end thereof outwardly of the extremity of said subcutaneous end portion thereof and (2) to be withdrawn from said interior passage in the opposite direction.

17. Apparatus as defined in claim 16 wherein the interior periphery of said cannula defining said interior passage has a cross-sectional configuration similar to said exterior cross-sectional configuration the exterior peripheral cross-sectional configuration of said trocar closely approximating said interior configuration.

18. Apparatus as defined in claim 17 wherein the subcutaneous end portion of said cannula has an opening therein spaced from said extremity extending from the exterior periphery thereof through one end point thereof into communication with said interior passage.

19. Apparatus as defined in claim 18 wherein the subcutaneous end portion of said cannula is formed with a stop surface on the exterior periphery facing toward said extremity and spaced therefrom a distance greater than the spacing of said opening.

20. Apparatus as defined in claim 19 wherein the extracorporeal end portion of said cannula has a stabilizing shield portion formed on the exterior periphery thereof.

21. Apparatus as defined in claim 20 wherein said interior passage includes a straight portion and an angularly related outlet portion, the extracorporeal end portion of said cannula including means disposed in longitudinal alignment with the straight portion of said interior passage for (1) enabling the insertion of said trocar pointed end first therethrough and into said interior passage (2) for enabling the trocar to be removed therefrom and (3) for preventing fluid flow therethrough after said trocar has been removed.

22. Apparatus as defined in claim 8 wherein said inlet to bloodstream communication establishing means and said outlet to bloodstream communication establishing means comprises a totally subcutaneous implant device, a blood withdrawing percutaneous cannula and trocar assembly removably cooperable with said implant and a blood returning percutaneous cannula and trocar assembly removably cooperable with said implant.

23. Apparatus as defined in claim 22 wherein said implant device comprises;

a body of elastomeric material adapted to be implanted totally subcutaneously in a femoral extremity,

means in said body defining an arterial passage, a spaced venous passage, and a bypass conduit extending from one end of said arterial passage to one end of said venous passage,

an arterial tube of vascular prosthesis material having one end connected in communicating relation with the other end of said arterial passage and an opposite end adapted to be connected with a main femoral artery side wall in communicating relation with the interior of the femoral artery,

a venous tube of vascular prosthesis material having one end connected in communicating relation with the other end of said venous passage and an opposite end adapted to be connected with a main femoral vein side wall in communicating relation with the interior of the femoral vein,

blood withdrawing percutaneous cannula receiving means in said elastomeric body extending from a position exterior of said elastomeric body inwardly thereof to a position in communicating relation with said arterial passage movable between (1) a closed condition excluding fluid containing space within said body between said two positions so that blood flowing from said arterial tube through said arterial passage will pass therefrom through said bypass conduit into said venous passage and out of said venous tube and (2) an open condition excluding fluid receiving space within said body from the exterior periphery of the portion of a blood withdrawing cannula extending between said two positions which also extends percutaneously and in communicating relation with said arterial passage so that blood flowing from said arterial tube through said arterial passage will flow through said blood withdrawing cannula and said bypass conduit, and

blood returning percutaneous cannula receiving means in said elastomeric body extending from a position exterior of said body inwardly thereof to a position in communicating relation with said venous passage movable between (1) a closed condition excluding fluid containing space within said body between said two positions so that blood flowing from said bypass conduit will pass therefrom into said venous passage and out of said venous tube, and (2) an open condition excluding fluid receiving space within said body from the exterior periphery of the portion of a blood returning cannula extending between said two positions which also extends percutaneously and in communicating relation with the venous passage so that said venous passage will receive blood flowing both from said blood returning cannula and said bypass conduit.

24. Apparatus as defined in claim 23 wherein said arterial passage, said bypass conduit and said venous passage are of generally U-shaped configuration.

25. Apparatus as defined in claim 24 wherein said blood withdrawing cannula receiving means comprises a slit in said body extending between the two positions associated therewith and said blood returning cannula receiving means comprises a slit in said body extending between the two positions associated therewith.

26. Apparatus as defined in claim 25 wherein the inner position of said arterial passage has a peripheral cross-sectional configuration which is elongated in one direction with sharp points defining opposite ends thereof in the direction of elongation and said venous passage has a peripheral cross-sectional configuration which is elongated in one direction with sharp points defining opposite ends thereof in the direction of said elongation, said slits being of a width generally equal to the distance between the end points of the associated passage and longitudinally aligned with a line extending between said end points.

27. Apparatus as defined in claim 26 including a metallic spring member associated with each slit including a tapered guide portion leading to the exterior of the associated slit and a pair of spaced finger portions resiliently urging the portions of said elastomeric body defining the associated slit surfaces together.

28. Apparatus as defined in claim 27 wherein said body of elastomeric material has fabric portions extending from the exterior thereof for enabling said body to be initially fixed by suture and subsequently semipermanently fixed by time ingrowth.

29. Apparatus for providing an extracorporeal blood circuit for connection with an arterio-venous shunt device systemically connected and subcutaneously implanted in a human patient for systemically treating the patient hyperthermically to retard the growth of cancer cells in the patient, comprising

means defining a sterile extracorporeal flow path for blood having an inlet, an outlet and a temperature control zone therebetween,

means for establishing communication of the inlet of said extracorporeal flow path through said subcutaneous shunt device with the patient'"'"'s blood stream so that blood can be withdrawn and supplied to said extracorporeal flow path without adversely affecting the blood circulation in the area from which the blood is withdrawn, and

means for establishing communication of the outlet of said extracorporeal flow path through said subcutaneous shunt device with the patient'"'"'s blood stream so that blood flowing from the extracorporeal flow path is returned to the blood stream in such a way as to be distributed systemically,

said flow path defining means including

a section of flexible tubing adapted to cooperate with pump means acting on the exterior of said tubing section to repetitively progressively collapse the section of flexible tubing in a direction to pump the blood withdrawn from the patient'"'"'s bloodstream along said extracorporeal flow path through said temperature control zone at a controlled rate of at least approximately one liter per minute and returning the same to the patient'"'"'s bloodstream to be distributed systemically, as aforesaid, and

heat exchanger means for directing the blood through the temperature control zone of said flow path,

said heat exchanger means having means for directing a substantially constant flow of temperature controlled liquid in heat exchange relation with respect to the blood flowing through said temperature control zone so that the temperature of the blood can be controlled for an initial period during which the temperature level of the blood flowing within the temperature control zone is raised without causing the same to reach localized temperatures in excess of approximately 45°

C. so that the systemic distribution of the returning blood gradually increases the patient'"'"'s core body temperature to a generally stable temperature condition at a level of approximately 41.5°

C. but not higher than approximately 42.5°

C. and the temperature of the blood can be maintained at said generally stable temperature for a second time period sufficient to effect the desired treatment.